The FDA in the United States approved the first closer-to-patient test on March 21, 2020 for use later this month. Diagnostic guidelines published by Zhongnan Hospital of Wuhan University suggest infection detection methods based on clinical features and epidemiological risk.
FDA nchini Marekani iliidhinisha jaribio la kwanza la utunzaji tarehe 21 Machi 2020 kwa ajili ya matumizi mwishoni mwa mwezi huo. Miongozo ya utambuzi iliyotolewa na Hospitali ya Zhongnan ya Chuo Kikuu cha Wuham ilipendendekeza mbinu za kugundua maambukizo kulingana na sifa za kliniki na hatari ya magonjwa ya mlipuko.